Skip to main content
Erschienen in: Journal of General Internal Medicine 4/2010

01.04.2010 | Original Article

Relationship of Opioid Use and Dosage Levels to Fractures in Older Chronic Pain Patients

verfasst von: Kathleen W. Saunders, JD, Kate M. Dunn, Ph. D, Joseph O. Merrill, M.D, M.P.H., Mark Sullivan, M.D., Ph.D., Constance Weisner, DrPH, M.S.W, Jennifer Brennan Braden, M.D., M.P.H., Bruce M. Psaty, M.D., Ph.D., Michael Von Korff, Sc.D.

Erschienen in: Journal of General Internal Medicine | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Opioids have been linked to increased risk of fractures, but little is known about how opioid dose affects fracture risk.

Objective

To assess whether risk of fracture increases with opioid dose among older patients initiating sustained use of opioids for chronic non-cancer pain.

Design

A cohort study that uses Cox proportional hazards models to compare fracture risk among current opioid users vs. persons no longer using opioids.

Participants

Members of an integrated health care plan (N = 2,341) age 60 years and older who received 3+ opioid prescriptions within a 90-day period for chronic, non-cancer pain between 2000 and 2005.

Measurements

Time-varying measures of opioid use and average daily dose in morphine equivalents were calculated from automated data. Fractures were identified from automated data and then validated through medical record review.

Results

Compared with persons not currently using opioids, opioid use was associated with a trend towards increased fracture risk (1.28 (95% CI (0.99, 1.64 )). Higher dose opioid use (≥50 mg/day) was associated with a 9.95% annual fracture rate and a twofold increase in fracture risk (2.00 (95% CI (1.24, 3.24)). Of the fractures in the study cohort, 34% were of the hip or pelvis, and 37% were associated with inpatient care.

Conclusions

Higher doses (≥50 mg/day) of opioids for chronic non-cancer pain were associated with a 2.00 increase in risk of fracture confirmed by medical record review. Clinicians should consider fracture risk when prescribing higher-dose opioid therapy for older adults.
Literatur
1.
Zurück zum Zitat Zerzan JT, Morden NE, Soumerai S, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006;44:1005–10.CrossRefPubMed Zerzan JT, Morden NE, Soumerai S, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006;44:1005–10.CrossRefPubMed
2.
Zurück zum Zitat Caudill-Slosberg M, Schwartz L, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004;109:514–9.CrossRefPubMed Caudill-Slosberg M, Schwartz L, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004;109:514–9.CrossRefPubMed
3.
4.
Zurück zum Zitat Martell BA, O’Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–27.PubMed Martell BA, O’Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–27.PubMed
5.
Zurück zum Zitat Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24(6):469–78.CrossRefPubMed Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24(6):469–78.CrossRefPubMed
6.
Zurück zum Zitat Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain:a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage. 2008;35:214–28.PubMed Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain:a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage. 2008;35:214–28.PubMed
7.
Zurück zum Zitat Kelly J, Cook S, Kaufman D, Anderson T, Rosenberg L, Mitchell A. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138:507–13.CrossRef Kelly J, Cook S, Kaufman D, Anderson T, Rosenberg L, Mitchell A. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138:507–13.CrossRef
8.
Zurück zum Zitat Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf. 2003;12:315–26.CrossRefPubMed Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf. 2003;12:315–26.CrossRefPubMed
9.
Zurück zum Zitat Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166:2087–93.CrossRefPubMed Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166:2087–93.CrossRefPubMed
10.
Zurück zum Zitat Braithwaite RS, Col N, Wong J. Estimating hip fracture morbidity, mortality and costs. JAGS. 2003;51:364–70.CrossRef Braithwaite RS, Col N, Wong J. Estimating hip fracture morbidity, mortality and costs. JAGS. 2003;51:364–70.CrossRef
11.
Zurück zum Zitat Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med. 2006;260:76–87.CrossRefPubMed Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med. 2006;260:76–87.CrossRefPubMed
12.
Zurück zum Zitat Ensrud K, Blackwell T, Mangione C, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003;163:949–57.CrossRefPubMed Ensrud K, Blackwell T, Mangione C, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003;163:949–57.CrossRefPubMed
13.
Zurück zum Zitat Vestergaard P. Pain-relief medication and risk of fractures. Curr Drug Saf. 2008;3:199–203.CrossRefPubMed Vestergaard P. Pain-relief medication and risk of fractures. Curr Drug Saf. 2008;3:199–203.CrossRefPubMed
14.
Zurück zum Zitat Shorr RI, Griffin MR, Daugherty JR, Ray WA. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol. 1992;47:M111–5.PubMed Shorr RI, Griffin MR, Daugherty JR, Ray WA. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol. 1992;47:M111–5.PubMed
15.
Zurück zum Zitat Guo Z, Wills P, Viitanen M, Fastborn J, Winblad B. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol. 1998;148:887–92.PubMed Guo Z, Wills P, Viitanen M, Fastborn J, Winblad B. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol. 1998;148:887–92.PubMed
16.
Zurück zum Zitat Kamal-Bahl S, Stuart B, Beers M. Propoxyphene use and risk for hip fractures in older adults. Am J Geriatr Pharmacother. 2006;4:219–26.CrossRefPubMed Kamal-Bahl S, Stuart B, Beers M. Propoxyphene use and risk for hip fractures in older adults. Am J Geriatr Pharmacother. 2006;4:219–26.CrossRefPubMed
17.
Zurück zum Zitat French D, Campbell R, Spehar A, Rubenstein LZ, Branch L, Cunningham F. National outpatient medication profiling: medications associated with outpatient fractures in community-dwelling elderly veterans. Br J Clin Pharmacol. 2007;63(2):238–44.CrossRefPubMed French D, Campbell R, Spehar A, Rubenstein LZ, Branch L, Cunningham F. National outpatient medication profiling: medications associated with outpatient fractures in community-dwelling elderly veterans. Br J Clin Pharmacol. 2007;63(2):238–44.CrossRefPubMed
18.
Zurück zum Zitat Spector W, Shaffer T, Potter E, Correa-de-Araujo R, Rhona Limcangco M. Risk factors associated with the occurrence of fractures in U.S. nursing homes: resident and facility characteristics and prescription medications. JAGS. 2007;55:327–33.CrossRef Spector W, Shaffer T, Potter E, Correa-de-Araujo R, Rhona Limcangco M. Risk factors associated with the occurrence of fractures in U.S. nursing homes: resident and facility characteristics and prescription medications. JAGS. 2007;55:327–33.CrossRef
19.
Zurück zum Zitat Abrahamsen B, Brixen K. Mapping the prescriptiome to fractures in men—a national analysis of prescription history and fracture risk. Osteoporosis Int. 2008; Aug 9 [Epub ahead of print]. Abrahamsen B, Brixen K. Mapping the prescriptiome to fractures in men—a national analysis of prescription history and fracture risk. Osteoporosis Int. 2008; Aug 9 [Epub ahead of print].
20.
Zurück zum Zitat Takkouche B, Montes-Martinez A, Gill S, Etminan M. Psychotropic medications and the risk of fracture. Drug Saf. 2007;30(2):171–84.CrossRefPubMed Takkouche B, Montes-Martinez A, Gill S, Etminan M. Psychotropic medications and the risk of fracture. Drug Saf. 2007;30(2):171–84.CrossRefPubMed
21.
Zurück zum Zitat Von Korff M, Saunders K, Ray T, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008;24(6):521–7.CrossRefPubMed Von Korff M, Saunders K, Ray T, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008;24(6):521–7.CrossRefPubMed
22.
Zurück zum Zitat Saunders K, Davis R, Stergachis A. Group Health Cooperative. In: Strom B, ed. Pharmacoepidemiology. West Sussex: John Wiley and Sons; 2005:223–39. Saunders K, Davis R, Stergachis A. Group Health Cooperative. In: Strom B, ed. Pharmacoepidemiology. West Sussex: John Wiley and Sons; 2005:223–39.
23.
Zurück zum Zitat Fishman P, Goodman M, Hornbrook M, et al. Risk adjustment using automated pharmacy data: the Rx Risk Model. Med Care. 2003;41:84–99.CrossRefPubMed Fishman P, Goodman M, Hornbrook M, et al. Risk adjustment using automated pharmacy data: the Rx Risk Model. Med Care. 2003;41:84–99.CrossRefPubMed
24.
Zurück zum Zitat Romano PS, Roos L, Jollis J. Further evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative data. J Clin Epidemiol. 1993;46:1085–90.CrossRef Romano PS, Roos L, Jollis J. Further evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative data. J Clin Epidemiol. 1993;46:1085–90.CrossRef
25.
Zurück zum Zitat Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med. 1995;332:767–73.CrossRefPubMed Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med. 1995;332:767–73.CrossRefPubMed
26.
Zurück zum Zitat Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer-Verlag; 2000. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer-Verlag; 2000.
27.
Zurück zum Zitat Cumming R. Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging. 1998;12:43–53.CrossRefPubMed Cumming R. Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging. 1998;12:43–53.CrossRefPubMed
28.
Zurück zum Zitat Wagner AK, Zhang F, Soumerai S, et al. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004;164:1567–72.CrossRefPubMed Wagner AK, Zhang F, Soumerai S, et al. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004;164:1567–72.CrossRefPubMed
29.
Zurück zum Zitat Kinjo M, Setoguchi S, Schneeweiss S, Solomon D. Bone mineral density in subjects using central nervous system-active medications. Am J Med. 2005;118:1414.e7–1414.e12.CrossRef Kinjo M, Setoguchi S, Schneeweiss S, Solomon D. Bone mineral density in subjects using central nervous system-active medications. Am J Med. 2005;118:1414.e7–1414.e12.CrossRef
30.
Zurück zum Zitat Haentjens P, Lamraski G, Boonen S. Costs and consequences of hip fracture occurrence in old age: an economic perspective. Disabil Rehabil. 2005;27:1129–41.CrossRefPubMed Haentjens P, Lamraski G, Boonen S. Costs and consequences of hip fracture occurrence in old age: an economic perspective. Disabil Rehabil. 2005;27:1129–41.CrossRefPubMed
31.
Zurück zum Zitat AGS Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc (in press). AGS Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc (in press).
32.
Zurück zum Zitat Barkin R, Barkin S, Barkin D. Perception, assessment, treatment and management of pain in the elderly. Clin Geriatr Med. 2005;21:465–90.CrossRefPubMed Barkin R, Barkin S, Barkin D. Perception, assessment, treatment and management of pain in the elderly. Clin Geriatr Med. 2005;21:465–90.CrossRefPubMed
Metadaten
Titel
Relationship of Opioid Use and Dosage Levels to Fractures in Older Chronic Pain Patients
verfasst von
Kathleen W. Saunders, JD
Kate M. Dunn, Ph. D
Joseph O. Merrill, M.D, M.P.H.
Mark Sullivan, M.D., Ph.D.
Constance Weisner, DrPH, M.S.W
Jennifer Brennan Braden, M.D., M.P.H.
Bruce M. Psaty, M.D., Ph.D.
Michael Von Korff, Sc.D.
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 4/2010
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-1218-z

Weitere Artikel der Ausgabe 4/2010

Journal of General Internal Medicine 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.